Global Information
회사소개 | 문의 | 위시리스트

중동의 자동 미생물 검사 시장 : 각종 분자진단 검사 판매량 및 판매액 예측, 공급업체의 점유율, 경쟁 전략, 검사기기, 기술

2017 Middle East Automated Microbiology Market: Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

리서치사 Venture Planning Group
발행일 상품 코드 448735
페이지 정보 영문 500 Pages
가격
US $ 8,250 ₩ 9,891,000 DataPack (Local license)
US $ 9,850 ₩ 11,810,000 PDF by E-mail (Local license)
US $ 15,700 ₩ 18,824,000 PDF by E-mail (Global license)


중동의 자동 미생물 검사 시장 : 각종 분자진단 검사 판매량 및 판매액 예측, 공급업체의 점유율, 경쟁 전략, 검사기기, 기술 2017 Middle East Automated Microbiology Market: Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies
발행일 : 페이지 정보 : 영문 500 Pages

중동 국가의 자동 미생물 검사(Automated Microbiology) 시장을 분석했으며, 검사 방법(분자진단약 등) 개요, 현재 및 향후의 기술 수준, 국가별 시장 동향 전망(향후 5년간 : 검사건수, 매출), 주요 공급업체 프로파일, 향후 시장 기회 등의 정보를 정리하여 전해드립니다.

1. 목차 및 도표

2. 국가별 시장 동향

  • 바레인
  • 이란
  • 이라크
  • 이스라엘
  • 요르단
  • 쿠웨이트
  • 레바논
  • 오만
  • 카타르
  • 사우디아라비아
  • 아랍에미리트(UAE)

3. 각종 질환용 분자진단약을 개발·출시하고 있는 주요 기업

  • AIDS
  • 아데노바이러스(Adenovirus)
  • 바르토넬라(Bartonella)
  • 캄피로박터(Campylobacter)
  • 칸디다(Candida)
  • 클라미디아(Chlamydia)
  • 클로스트리듐(Clostridium)
  • 코로나바이러스(Coronavirus)
  • 크립포스포리듐(Cryptosporidium)
  • 거대세포바이러스(CMV)
  • 에코바이러스(Echovirus)
  • 엔테로바이러스(Enterovirus)
  • 앱스타인바 바이러스(EBV)
  • 지아르디아(Giardia)
  • 임질(Gonorrhea)
  • 한타바이러스(Hantavirus)
  • 헬리코박터 파일로리(Helicobacter Pylori)
  • 간염(Hepatitis)
  • 포진(Herpes)
  • 인플루엔자(Influenza)
  • 레지오넬라(Legionella)
  • 라임병(Lyme Disease)
  • 림프 육아종(Lymphogranuloma)
  • 말라리아(Malaria)
  • 홍역(Measles)
  • 수막염(Meningitis)
  • 미포자충류(Microsporidium)
  • 단핵증(Mononucleosis)
  • 볼거리(Mumps)
  • 마이코플라즈마(Mycoplasma)
  • 유두종 바이러스(Papilloma Virus)
  • 파보바이러스(Parvovirus)
  • 폐렴(Pneumonia)
  • 호흡기 세포융합바이러스(RSV)
  • 로타바이러스(Rotavirus)
  • 풍진(Rubella)
  • 살모넬라균(Salmonella)
  • 패혈증(Septicemia)
  • 이질균(Shigella)
  • 포도상구균(Staphylococci)
  • 연쇄구균(Streptococci)
  • 매독(Syphilis)
  • 주혈원충병(Toxoplasmosis)
  • 트리코모나스(Trichomonas)
  • 결핵(Tuberculosis)
  • 웨스트 나일 바이러스(West Nile)
  • 예르시니아(Yersinia)
LSH 17.03.06

This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test.

The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive 11-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Country Analyses

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

Specimen Types

- Urine Sterile Fluids: Blood, Serum, CSF Throat Swabs, Respiratory Secretions Genital Secretions Stool Abscess/Wound Sputum Saliva

Applications

- Microbial Identification  Antibiotic Susceptibility  Urine Screening  Blood Cultures

Review of Major Automated Systems

- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.

- Companies developing or marketing microbiology products, by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategic Recommendations

- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains over 500 pages and 54 tables

Table of Contents

List of Tables

  • Bahrain
  • Microbiology Specimen Volume Forecast by Type
  • Bahrain
  • Microbiology Test Volume Forecasts by Application
  • Bahrain
  • Microbiology Consumables Market Forecast by Application
  • Bahrain
  • Infectious Disease Test Volume Forecast by Assay
  • Bahrain
  • Infectious Disease Diagnostics Market Forecast by Test
  • Bahrain
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Bahrain
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Iran
  • Microbiology Specimen Volume Forecast by Type
  • Iran
  • Microbiology Test Volume Forecasts by Application
  • Iran
  • Microbiology Consumables Market Forecast by Application
  • Iran
  • Infectious Disease Test Volume Forecast by Assay
  • Iran
  • Infectious Disease Diagnostics Market Forecast by Test
  • Iran
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Iran
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Iraq
  • Microbiology Specimen Volume Forecast by Type
  • Iraq
  • Microbiology Test Volume Forecasts by Application
  • Iraq
  • Microbiology Consumables Market Forecast by Application
  • Iraq
  • Infectious Disease Test Volume Forecast by Assay
  • Iraq
  • Infectious Disease Diagnostics Market Forecast by Test
  • Iraq
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Iraq
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Israel
  • Microbiology Specimen Volume Forecast by Type
  • Israel
  • Microbiology Test Volume Forecasts by Application
  • Israel
  • Microbiology Consumables Market Forecast by Application
  • Israel
  • Infectious Disease Test Volume Forecast by Assay
  • Israel
  • Infectious Disease Diagnostics Market Forecast by Test
  • Israel
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Israel
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Jordan
  • Microbiology Specimen Volume Forecast by Type
  • Jordan
  • Microbiology Test Volume Forecasts by Application
  • Jordan
  • Microbiology Consumables Market Forecast by Application
  • Jordan
  • Infectious Disease Test Volume Forecast by Assay
  • Jordan
  • Infectious Disease Diagnostics Market Forecast by Test
  • Jordan
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Jordan
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Kuwait
  • Microbiology Specimen Volume Forecast by Type
  • Kuwait
  • Microbiology Test Volume Forecasts by Application
  • Kuwait
  • Microbiology Consumables Market Forecast by Application
  • Kuwait
  • Infectious Disease Test Volume Forecast by Assay
  • Kuwait
  • Infectious Disease Diagnostics Market Forecast by Test
  • Kuwait
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Kuwait
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Lebanon
  • Microbiology Specimen Volume Forecast by Type
  • Lebanon
  • Microbiology Test Volume Forecasts by Application
  • Lebanon
  • Microbiology Consumables Market Forecast by Application
  • Lebanon
  • Infectious Disease Test Volume Forecast by Assay
  • Lebanon
  • Infectious Disease Diagnostics Market Forecast by Test
  • Lebanon
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Lebanon
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Oman
  • Microbiology Specimen Volume Forecast by Type
  • Oman
  • Microbiology Test Volume Forecasts by Application
  • Oman
  • Microbiology Consumables Market Forecast by Application
  • Oman
  • Infectious Disease Test Volume Forecast by Assay
  • Oman
  • Infectious Disease Diagnostics Market Forecast by Test
  • Oman
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Oman
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Qatar
  • Microbiology Specimen Volume Forecast by Type
  • Qatar
  • Microbiology Test Volume Forecasts by Application
  • Qatar
  • Microbiology Consumables Market Forecast by Application
  • Qatar
  • Infectious Disease Test Volume Forecast by Assay
  • Qatar
  • Infectious Disease Diagnostics Market Forecast by Test
  • Qatar
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Qatar
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Saudi Arabia
  • Microbiology Specimen Volume Forecast by Type
  • Saudi Arabia
  • Microbiology Test Volume Forecasts by Application
  • Saudi Arabia
  • Microbiology Consumables Market Forecast by Application
  • Saudi Arabia
  • Infectious Disease Test Volume Forecast by Assay
  • Saudi Arabia
  • Infectious Disease Diagnostics Market Forecast by Test
  • Saudi Arabia
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Saudi Arabia
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • United Arab Emirates
  • Microbiology Specimen Volume Forecast by Type
  • United Arab Emirates
  • Microbiology Test Volume Forecasts by Application
  • United Arab Emirates
  • Microbiology Consumables Market Forecast by Application
  • United Arab Emirates
  • Infectious Disease Test Volume Forecast by Assay
  • United Arab Emirates
  • Infectious Disease Diagnostics Market Forecast by Test
  • United Arab Emirates
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • United Arab Emirates
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
Back to Top
전화 문의
F A Q